A plethora of SBIR/STTR funding opportunities are either open now or will be in the near future. Below are several opportunities with links to the agency funding websites.
NIH
The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for the SBIR and STTR programs are now available. The first application due date is Tuesday, September 5, 2023.
- PA-23-230: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PA-23-231: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PA-23-232: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PA-23-233: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
DOE
Solicitations for the DOE SBIR/STTR program are open. A letter of intent is due to be submitted to DOE by 8/28 and full proposals are due on 10/10.
USDA
Solicitation for proposals was released on 7/7/23. Phase I proposals for USDA are due by 9/19/23.
NIFA’s SBIR/STTR programs offer 10 topic areas that are intended to permit a broad spectrum of eligible and innovative science- and technology-based small businesses to compete for funding. You can review that list here.
NSF
Small businesses can submit a Project Pitch at any time. Small businesses that have been invited to submit a full proposal can submit a proposal based on that Project Pitch at any time during one of the submission windows. The current window is July 6 – November 1, 2023. Solicitations are available here.
EPA
Phase 1 submissions are due 8/23. Click here for funding opportunities.
DOD
Pre-solicitations for DoD’s SBIR 23.3 / STTR 23.C round will open on 8/23. Full solicitations will open on 9/20 and proposal are due on 10/18. Click here for more information.
Want to receive this information directly in your inbox? Sign up for the newsletter here.